Multi-Center Trial to Evaluate the Efficacy and Safety of Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression (ANRS 105 INTERVAC)
Sponsor study identifier
interventional
200
1 country
1
Study Start
December 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
January 2005
Date type not reportedThis date has not been verified as actual or estimated.
The purpose of this study is to determine whether the adjunctional of interferon alfa to structured treatment interruptions correlated with a long time off treatment in HIV-1 infection.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2005
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2001
Date type not reportedThis date has not been verified as actual or estimated.
January 2005
Date type not reportedThis date has not been verified as actual or estimated.
August 1, 2005
Actual (reported)August 2, 2005
Actual (reported)Proportion of patients who did not reach the criteria to resume antiretroviral treatment at week 72 [W 72] (viral load over 30000 cp/ml at two consecutive monthly samples and/or CD4 count below 350/mm3 at two consecutive monthly samples)
Viral rebound one and 3 months after stopping all antiviral treatments
Specific anti-HIV CD4 and CD8 response
Proviral HIV DNA at baseline and during follow-up
Description of genetic HIV viral mutations during procedure
Safety
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Service de Medecine Interne
Clamart, 92140, France
François Boue, MD
Hopital Antoine Beclere service de Medecine Interne Clamart France
Dominique Costagliola
INSERM U 720
First Submitted
August 1, 2005
First Posted
August 2, 2005
Study Start
December 2001
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
January 2005
Date type not reportedRandomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)
Contact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
August 16, 2005
Record last verified: 2005-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: